Orange Book product · Generic (ANDA)
GENTAMICIN SULFATE
GENTAMICIN SULFATE
At a glance
Jul 30, 2004
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 30, 2004
22 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
GENTAMICIN SULFATE
Strength
EQ 0.3% BASE
Dosage form
OINTMENT
Route
OPHTHALMIC
TE code
Not listed
Application
ANDA 065024
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of GENTAMICIN SULFATE
- —GARAMYCINBrand (NDA)
NDA 050505 · SCHERING
- —GARAMYCINBrand (NDA)
NDA 050425 · SCHERING
- —GARAMYCINBrand (NDA)
NDA 050039 · SCHERING
- 2024GENTAMICIN SULFATEGeneric (ANDA)
ANDA 215236 · EUGIA PHARMA
- 2024GENTAMICIN SULFATEGeneric (ANDA)
ANDA 215237 · EUGIA PHARMA
- 2018GENTAMICIN SULFATEGeneric (ANDA)
ANDA 209233 · ENCUBE
- 1995GENTAMICIN SULFATEGeneric (ANDA)
ANDA 064093 · SCIEGEN PHARMS
- 1994GENTAMICIN SULFATEGeneric (ANDA)
ANDA 064056 · COSETTE PHARMS NC
- 1994GENTAMICIN SULFATEGeneric (ANDA)
ANDA 064054 · COSETTE PHARMS NC
- 1991GENTAMICIN SULFATEGeneric (ANDA)
ANDA 063149 · TEVA PARENTERAL
- 1991GENTAMICIN SULFATEGeneric (ANDA)
ANDA 063106 · TEVA PARENTERAL
- 1987GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 062814 · B BRAUN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
